Nd: YAG /Er: YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial
BJOG: An International Journal of Obstetrics & Gynaecology · 2024-05 · 131 (6) · 740-749
DOI: 10.1111/1471-0528.17737 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 27.12.2023. Verfasst von Irena Zivanovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Lasers, Solid-State. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy and safety of a novel non‐ablative Nd:YAG/Er:YAG dual laser treatment for vulvar lichen sclerosus (LS) in comparison with the recommended first‐line therapy with topical steroid.
Design
A randomised investigator‐initiated active‐controlled trial.
Setting
Single tertiary referral centre. Population Women with vulvar LS.
Methods
Randomisation (2:1) to Nd:YAG/Er:YAG laser therapy or topical clobetasol proprionate therapy. Four laser treatments at 0, 1, 2 and 4 months or decreasing doses of steroid for 6 months. Main Outcome Measures The primary outcome was the change in objective validated clinical LS score in the laser arm between baseline and 6 months. Secondary outcomes were laser tolerability/safety, symptom scores and patient satisfaction.
Results
Sixty‐six women were included, 44 in the laser group and 22 in the steroid group. The total LS score decreased by −2.34 ± 1.20 (95% CI −2.71 to −1.98) in women treated with laser compared with a decrease of −0.95 ± 0.90 (95% CI −1.35 to −0.56) in those receiving steroid applications ( p < 0.001). Laser treatment was safe and well tolerated. Subjective severity scores (on visual analogue scale) and vulvovaginal symptoms questionnaire scores improved similarly for the laser and steroid arms without significant differences between the two treatments. Patient satisfaction was higher in the laser arm than in the steroid arm ( p = 0.035).
Conclusions
Non‐ablative dual Nd:YAG/Er:YAG laser therapy was safe and significantly improved clinical outcome and subjective symptoms at the 6‐month follow up. This suggests that laser may be a promising alternative to corticosteroid therapy. However, the authors caution regular follow ups because of the premalignant nature of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland.
- Diagnostic and Research Institute of Pathology, Medical University Graz, Graz, Austria.
ORCID-Profile: Marianne Gamper, Sigrid Regauer, Volker Viereck
Zitieren
APA
Zivanovic, I., Gamper, M., Fesslmeier, D., Walser, C., Regauer, S., & Viereck, V. (2024). Nd: YAG /Er: YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, 131(6), 740-749. https://doi.org/10.1111/1471-0528.17737
Vancouver
Zivanovic I, Gamper M, Fesslmeier D, Walser C, Regauer S, Viereck V. Nd: YAG /Er: YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2024;131(6):740-749. doi:10.1111/1471-0528.17737
BibTeX
@article{Zivanovic2024,
author = {Zivanovic, Irena and Gamper, Marianne and Fesslmeier, Debra and Walser, Claudia and Regauer, Sigrid and Viereck, Volker},
title = {Nd: YAG /Er: YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: A randomised controlled trial},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
volume = {131},
number = {6},
pages = {740--749},
doi = {10.1111/1471-0528.17737}
}
EUVIMED